© 2021 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Atopic Dermatitis
Looking at systemic treatment for atopic dermatitis
July 21, 2021
New and forthcoming options bring opportunity for optimizing patient care.
Certain probiotics may reduce the risk of atopic dermatitis
June 02, 2021
Can probiotics help with atopic dermatitis risk? A meta-analysis offers some answers.
Approaches to skin conditions vary with skin color
May 03, 2021
The signs of dermatologic conditions can be different in skin of color. A report offers clinical pearls on how to examine and treat common conditions in skin of color.
Impact of atopic dermatitis on learning
April 20, 2021
According to objective and subjective measures, children with more severe atopic dermatitis were more likely to report a learning disability.
What you need to know about atopic dermatitis
April 12, 2021
Atopic dermatitis is a chronic, inflammatory skin condition that affects 15% to 20% of children and 1% to 3% of adults in the United States. The prevalence of atopic dermatitis, which is also known as eczema, is increasing in developing and industrialized countries.
Should some infants be screened before peanut introduction?
March 23, 2021
An investigation examines which infants might require screening before peanut introduction.
Can early exposure to farm animals reduce atopic dermatitis risk?
January 01, 2021
Spending time around animals as an infant has been suggested as a way to reduce the incidence of atopic dermatitis. An investigation offers some insight.
Looking at atopic dermatitis treatment options
July 24, 2020
Atopic dermatitis treatment has dramatically changed over the years. Here’s a look at the current options.
FDA approves dupilumab for atopic dermatitis treatment in pediatrics
May 26, 2020
The US Food and Drug Administration has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years.